- Home
- ASA vs PSNL Comparison
ASA vs PSNL Comparison
Compare ASA & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- PSNL
- Stock Information
- Founded
- ASA 1958
- PSNL 2011
- Country
- ASA United States
- PSNL United States
- Employees
- ASA N/A
- PSNL N/A
- Industry
- ASA Precious Metals
- PSNL Medical Specialities
- Sector
- ASA Industrials
- PSNL Health Care
- Exchange
- ASA Nasdaq
- PSNL Nasdaq
- Market Cap
- ASA 549.0M
- PSNL 460.7M
- IPO Year
- ASA N/A
- PSNL 2019
- Fundamental
- Price
- ASA $28.26
- PSNL $4.82
- Analyst Decision
- ASA
- PSNL Strong Buy
- Analyst Count
- ASA 0
- PSNL 5
- Target Price
- ASA N/A
- PSNL $8.00
- AVG Volume (30 Days)
- ASA 79.6K
- PSNL 769.8K
- Earning Date
- ASA 05-30-2025
- PSNL 05-06-2025
- Dividend Yield
- ASA 0.18%
- PSNL N/A
- EPS Growth
- ASA N/A
- PSNL N/A
- EPS
- ASA 11.67
- PSNL N/A
- Revenue
- ASA $3,557,386.00
- PSNL $85,694,000.00
- Revenue This Year
- ASA N/A
- PSNL $1.30
- Revenue Next Year
- ASA N/A
- PSNL $26.23
- P/E Ratio
- ASA $2.47
- PSNL N/A
- Revenue Growth
- ASA 45.39
- PSNL 15.57
- 52 Week Low
- ASA $16.97
- PSNL $1.14
- 52 Week High
- ASA $31.94
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- ASA 45.49
- PSNL 62.86
- Support Level
- ASA $29.92
- PSNL $3.98
- Resistance Level
- ASA $30.85
- PSNL $5.39
- Average True Range (ATR)
- ASA 0.83
- PSNL 0.38
- MACD
- ASA -0.28
- PSNL 0.13
- Stochastic Oscillator
- ASA 7.54
- PSNL 60.30
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.